Guest mode: your portfolio is kept in this browser until you connect.

Sys onlineGuest--:-- local
BAXhealthcarenyse

BABaxter International

Baxter International (BAX) is a healthcare company; Yahoo Finance files it under medical instruments & supplies.

Price

$25.79

+0.55% on Nov 6

Risk

High

48.6% vol · 30d

share this asset

Key facts, as of

As of November 6, 2026, Baxter International (BAX) trades at $25.79, up 43.4% over the past year. Its 52-week range runs from $15.73 to $30.00; the price is 14.0% below that high. It is 72.9% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of October 2026, with dividends reinvested, it returned −43.6%, against +316.3% for the S&P 500 (SPY). It sits 20.1% above its 200-day average of $21.48, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 48.6% annualized, which we rate high risk. It has a dividend yield of 0.16%.

Cite: Portfolio Terminal, "Baxter International (BAX) stock analysis", 2026-11-06. https://portfolio-terminal.com/analyse/bax

01Market

Where it trades today

Market cap

$13.34B

Price / earnings

N/A

Beta

0.67

swings less than the market

Dividend yield

0.16%

Volume

6.19M

avg 6.62M

50-day average

$24.50

200-day average

$21.48

30-day move

+7.9%

52-week range14.0% below the high
low $15.73$25.79high $30.00

trading 70% of the way up its 52-week range

02Price

How the price has moved

30-day price+7.91%
30 days ago$23.90 → $25.79today
1-year performance+39.6%
$19$22$25NovDecJanFebMarAprMayJunJulAugSepOct
BAX · 52 weeks$18.47 → $25.79
03History

How far it is from its record

All-time high

$95.19

Apr 2020, intraday

From the high

−72.9%

+269.1% to regain it

History from

Jan 1985

monthly, Yahoo Finance

10 years

−43.6%

SPY +316.3%

Baxter International (BAX) is 72.9% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of October 2026, with dividends reinvested, it returned −43.6%, against +316.3% for the S&P 500 (SPY).

BAX since Jan 1985−72.9% from the high
$49$74$25.79$95.19 · Apr 20201990200020102020
Month-end closes, split-adjusted · dashed: today
04Read

The read, from its own figures

the read3 sources

What its numbers say

  • BAX closes above its 50-day average ($24.50), and the 50-day sits above the 200-day ($21.48): on both averages the chart reads as an uptrend.
  • At $25.79, BAX is 14.0% below its 1-year high of $30.00, set on July 30, 2026, and 64.0% above its 1-year low of $15.73 (March 30, 2026).
  • Over the past month BAX rose 7.9%, from $23.90 to $25.79.
  • BAX's 30-day volatility, 48.6% a year, works out to a typical daily move of about 3.1%.
  • Yahoo Finance puts its beta at 0.67: over five years of monthly returns, BAX moved about 0.67% for each 1% move of the S&P 500.

What would change the read

  • A close under the 50-day average, $24.50 (−5.0% from the last close), would turn the read to a pullback; under the 200-day, $21.48 (−16.7%), the longer rise is in question.
  • A close above $30.00 (+16.3%) would be a new 1-year high; below $15.73 (−39.0%), a new 1-year low.

How it is computed

  • Prices are Yahoo Finance's daily candles for BAX, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
  • The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
  • Peers are the other companies Yahoo Finance files under medical instruments & supplies among the assets we track, not a full industry screen; the median counts those with a positive P/E.
  • Every sentence here is written by code from those figures, refreshed daily; nobody edits it for BAX by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.

Sources

  • Yahoo Finance quote and daily historyopen →

    The candles, the averages' inputs and the quote fields used for BAX. Last refresh: Nov 8, 2026, 10:53 PM UTC.

  • How Portfolio Terminal computes its figuresopen →

    The methodology page behind the analytics and their refresh cadence.

  • Industry classification

    Yahoo Finance's industry, as stored in our list of tracked assets: Medical Instruments & Supplies.

Computed, not written · Code turns the figures above into these sentences; market data refreshed 11/8/2026, 10:53:31 PM. Page built by Julien Esnault. A description of the data, not advice.
05About

What Baxter International does

profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision…

Employees

37,500

Industry

Medical Instruments & Supplies

Headquarters

Deerfield, United States

06Analyst Consensus

What analysts expect

BAX carries a hold consensus from 12 analysts, with an average price target of $27.25 versus $25.79 today (+5.7%). Targets are estimates and can move quickly after earnings.

Consensus

Hold

Average target

$27.25

$23.00 to $40.00

Upside to target

+5.7%

Analysts covering

12

Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.

07Financial Strength

How the business is doing

BAX generated $11.61B in trailing revenue (5.0% year over year), with a -6.2% net margin, and $1.22B of free cash flow, against $6.83B of net debt.

Revenue (TTM)

$11.61B

Net margin

-6.2%

Revenue growth

5.0%

Free cash flow

$1.22B

Gross margin

33.4%

Operating margin

9.9%

Return on equity

-9.0%

Total cash

$1.98B

Total debt

$8.81B

Earnings growth

N/A

08Annual Financials

The numbers, year by year

annual financials4 years
Fiscal yearRevenueGross profitOperating incomeNet incomeEPSFree cash flow
2025$11.24B$3.38B$177.00M-$957.00M-$1.87$323.00M
2024$10.64B$3.98B$439.00M-$649.00M-$1.27$559.00M
2023$10.36B$4.15B$707.00M$2.66B$5.25$1.29B
2022$10.06B$3.55B-$33.00M-$2.43B-$4.83$576.00M
Company filings via Yahoo Finance. Refreshed 11/8/2026.
09Next Earnings

When it reports next

Next report

Oct 29, 2026

EPS estimate

$0.60

Revenue estimate

$3.09B

Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.

10ETFs

Which ETFs hold it

BAX is in 12 of the 54 ETFs we track. It weighs most in RSP: 0.21% of the fund, holding #163 of 504.

etfs holding it12 of 54 funds
RSP0.21%#163 of 504XLV0.20%#52 of 62VB0.16%#165 of 1,301VYM0.05%#250 of 593SPY0.02%#449 of 504IVV0.02%#449 of 503CSPX0.02%#450 of 503VOO0.02%#452 of 505VUAA0.02%#453 of 503ITOT0.02%#548 of 2,423VTI0.02%#564 of 3,516VT0.01%#1228 of 10,155
11Industry

How its figures compare with those peers

versus its peersBAX vs the median of ISRG, HOLX
metricBAXmedian · ngap
beta0.671.44 · 1−53%
dividend yield0.16%0.00% · 1—
30-day volatility48.6%43.5% · 1+12%
Live Yahoo Finance figures for each name; n counts the peers that have the figure.
12Peers

Companies in the same industry

BAX beside the other companies Yahoo Finance files under medical instruments & supplies among the assets we track (ISRG, HOLX, largest first).

peers3 companies
companypricemarket cap
BABAX$25.79$13.34B
Intuitive Surgical logoISRG$452.80$156.96BHOHOLX—N/A
Any row opens that company's own analysis.
13Technicals

What the chart is saying

In an uptrend, above both moving averages.

uptrend
bax · daily
50-day 24.50200-day 21.48resistancesupport
17.5020.0027.5030.007030RSI 14 · 56volS 23.62S 22.4925.79JunJulAugSepOctNov
Daily candles · BAXLevels are zones where the price turned at least twice in the last year. Last close $25.79 on 2026-11-06.

RSI (14)

56

neutral zone

vs 50-day

+5.2%

avg $24.50

vs 200-day

+20.1%

avg $21.48

From 1-year high

−14.0%

high $30.00 · 2026-07-30

levels and the read49% annualized vol · 30d
support$23.62turned here 3×−8.4%
support$22.49turned here 3×−12.8%
  • Price is 5.2% above its 50-day average and 20.1% above its 200-day.
  • The 50-day crossed above the 200-day on 2026-07-13 (a “golden cross”).
  • RSI at 56 is neither stretched nor washed out.
  • Nothing above has stopped it this year; the nearest floor is $23.62 (-8.4%).

A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.

14Questions

Questions people ask about it

questions7 answered

What is the risk level of BAX?

Based on 30-day volatility of 48.6%, BAX has HIGH risk. Its beta of 0.67 means it has swung less than the S&P 500 over the last five years.

Does BAX pay dividends?

Yes, Baxter International has a dividend yield of 0.16%.

How far is BAX from its all-time high?

Baxter International is 72.9% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of October 2026, with dividends reinvested, it returned −43.6%, against +316.3% for the S&P 500 (SPY).

Which ETFs hold BAX?

12 of the 54 popular ETFs we track hold Baxter International. The largest weights: RSP (0.21%), XLV (0.20%), VB (0.16%), VYM (0.05%) and SPY (0.02%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.

How much of VOO is BAX?

0.02%, as of September 30, 2026: BAX is holding #452 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.19 in Baxter International.

What is the analyst price target for BAX?

The average analyst price target for Baxter International (BAX) is $27.25 based on 12 analyst estimates, about 5.7% above the current price of $25.79. The published range runs from $23.00 to $40.00.

How much revenue does BAX generate?

Baxter International reported $11.61B in trailing twelve-month revenue. Revenue growth is running at 5.0% year over year. Net margin sits at -6.2%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.

Compare BAX with anything

Five years side by side: what $10,000 became, how far each fell, whether they move together.

BA